Jacobson Pharma Corporation Limited (“Jacobson Pharma” or “the Group”; Stock Code: 2633.HK), a leading company engaged in the research, development, production, marketing and sale of essential medicines and branded healthcare…
Delivers Solid Performance Amidst Market Challenges; Revenue Increases +6.3%; Maintains Full-Year Dividend Per Share of HK4.5 Cents Jacobson Pharma Corporation Limited (“Jacobson Pharma” or the “Company”; Stock Code: 2633), a…
HONG KONG, Nov 12, 2019 – (ACN Newswire) – Jacobson Pharma Corporation Limited (“Jacobson Pharma” or the “Group”; Stock Code: 2633), a leading company engaging in research, development, production, marketing…
Jacobson Pharma Corporation Limited (“Jacobson Pharma” or the “Company”; Stock Code: 2633), a leading company engaged in research, development, production, marketing and sale of generic drugs and proprietary medicines, announced…
Jacobson Pharma Corporation Limited (“Jacobson Pharma” or the “Group”; Stock Code: 2633), a leading company engaging in the research, development, production, marketing and sale of generic drugs and proprietary medicines,…
Profit from Operations Leapt by 40.7% to HK$158.6 Million; Declares Interim Dividend of HK1.5 cents per share; Growth Strategies to Tap Innovative Pharma Market and Expand Regional Presence HONG KONG…
HONG KONG — Jacobson Pharma Corporation Limited (“Jacobson Pharma” or the “Group”; Stock Code: 2633), a leading company engaged in the research, development, production, marketing and sale of generic drugs…
